Zhu et al. demonstrated that tumor infiltration by M2-polarized TAMs and MDSCs could be reduced in a mouse model of pancreatic ductal adenocarcinoma with colony-stimulating factor 1 receptor (CSF1R) inhibitors. This evidence concerns the gene CSF1R and neoplasm.